Open AccessFunctional activity of the membrane‐asssociated complement inhibitor CD59 in a pig‐to‐human in vitro model for hyperacute xenograft rejection
Author(s) -
HECKLÖSTREICHER B.,
BINDER R.,
KIRSCHFINK M.
Publication year - 1995
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.1995.tb03857.x
Subject(s) - cd59 , complement membrane attack complex , complement system , decay accelerating factor , xenotransplantation , cd46 , transfection , biology , microbiology and biotechnology , endothelial stem cell , phospholipase c , cell culture , in vitro , immunology , immune system , biochemistry , transplantation , medicine , signal transduction , genetics
SUMMARY Hyperacute rejection triggered by activation of the recipient's complement system represents the major barrier to successful xenotransplantation. Transfer of human membrane‐associated complement regulators to donor organs has been suggested as one strategy to interfere with complement‐mediated hyperacute xenograft rejection. Pigs are discussed as potential organ donors. We therefore investigated a putative protective function of the membrane‐bound complement inhibitor CD59 in a pig‐to‐human in vitro model of hyperacute xenograft rejection. Aortic porcine endothelial cells were transfected with human CD59 cDNA. Expression of human CD59 was demonstrated by cytofluorimetric and RNA analysis. Removal of CD59 from the cell surface by phosphatidylinositol‐specific phospholipase C (PI‐PLC) demonstrated its production as a glycosyl phosphatidylinositol (GPI)‐anchored protein. Functional activity of the transfected CD59 was tested by a lactate dehydrogenase (LDH) release assay for complement‐mediated lysis. Porcine endothelial ceils expressing human CD59 were significantly protected from lysis by human serum complement compared with CD59 ‐ cells. The protective effect was abolished by preincubating the cells with anti‐CD59 antibodies or PI‐PLC. We calculated by Scatchard analysis that the established CD59 + cell line expressed a CD59 level comparable to that of human endothelial cells. Our results recommend the production of pigs transgenic for CD59.